Evaluation of a diphtheria and tetanus PLGA microencapsulated vaccine formulation without stabilizers

Current Drug Delivery

Volumn 6, Issue 3, 2009, Pages 297-304

  Quintilio, Wagner ^a   Takata, Célia S ^a   Sant'Anna, Osvaldo A ^a   Da Costa, Maria Helena B ^a   Raw, Isaías ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Diphtheria toxoid; PLGA microspheres; Single shot vaccine; Tetanus toxoid

Indexed keywords

DIPHTHERIA TETANUS TOXOID; NEUTRALIZING ANTIBODY; POLYGLACTIN;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNIZATION; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; BIOLOGICAL AVAILABILITY; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS VACCINE; DRUG COMPOUNDING; FEMALE; GUINEA PIGS; IMMUNOGLOBULIN G; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; TETANUS TOXOID; VACCINATION;

EID: 67650093436     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109788680886     Document Type: Article

References (27)

1. th, 2008.
2. Johansen, P.; Martínez Gómez, J. M., Gander B. Development of synthetic biodegradable microparticulate vaccines: a roller coaster story. Exp. Rev. of Vaccines, 2007, 6, 471-474 (Pubitemid 47304024)
3. Aguilar, J.C.; Rodríguez, E.G. Vaccine adjuvants revisited. Vaccine, 2007, 2, 3752-3762
4. Cleland, J.L. Design and production of single immunization vaccines using polylactide polyglicolide microspheres systems. In: Powell, M.F., Newman, M.J. (Ed.), Vaccine design: the subunit and adjuvant approach, Plenum Press: New York, 1995.
5. Zhu, G.; Schwendeman, S.P. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives. Pharm Res., 2000, 17(3), 351-357 (Pubitemid 30225140)
6. Jiang, W; Schwendeman, S.P. Stabilization of Tetanus Toxoid Encapsulated in PLGA Microspheres, Mol. Pharmaceutics, 2008, http://pubs3.acs.org/acs/ journals/doilookup?in-doi=10.1021/mp800 027f
7. Kang, J.; Schwendeman, S.P. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants. Biomaterials, 2002, 23(1), 239-245 (Pubitemid 33041359)
8. Tamber, H.; Johansen, P.; Merkle H.P.; Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv. Drug Deliv. Rev., 2005, 57(3), 357-376 (Pubitemid 39555502)
9. Costa, M.H.B.; Fattal, E. Comparative study of the systemic immune response against a heat shock protein associated to different delivery systems, Proceedings of the Symposium of Controlled Release Bioactive Materials.# 6707, 2000.
10. Namur, J.A.M.; Cabral-Albuquerque, E.C.M.; Quintilio, W.; Santana, M.H.A.; Politi, M.J.; de Araújo, P.S.; Lopes, A.C.; Costa, M.H.B. PLGA microparticle sizes: a rational factorial design and surface response analysis. J. Nanosci. Nanotech., 2005, 6, 1-5.
11. Xing, D.K.L.; McLellan, K.; Corbel, M.J.; Sesardic, D. Estimation of antigenic tetanus toxoid extracted from bidegradable microspheres. Biologicals, 1996, 24, 57-65. (Pubitemid 26148443)
12. Peterson, G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem., 1977, 83, 346-356 (Pubitemid 8269786)
13. Souza-Matos, D.C.; Marcovistz, R.; Cabello, P.H.; Georgini, R.A.; Sakauchi, D.; da Silva, L.L. Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test. Mem. Inst. Oswaldo Cruz., 2002, 97(6), 909-913 (Pubitemid 135745947)
14. Marcovistz, R.; Matos, D.C.; Georgini, R.A.; Sakauchi, D. Potency control of diphtheria component in adsorbed vaccines by in vitro neutralization tests. Biologicals, 2002, 30(2), 105-112 (Pubitemid 36284689)
15. Eldridge, J.H.; Staas, J.K.; Meulbroek, J.A.; Tice, T.R.; Gilley, R.M. Biodegradable and biocompatible poly(DL-lactide-coglycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid wich enhances the level of toxin-neutralizing antibodies. Infect. Immun., 1991, 59, 2978-2986
16. Johansen, P.; Corradin, G.; Merkle, H.P.; Gander, B. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern. J. Control. Release., 1998, 56(1-3), 209-217 (Pubitemid 28511141)
17. Jaganathan, K.S.; Rao, Y.U.B.; Singh, P.; Prabakaran, D.; Gupta, S.; Jain, A.; Vyas, S.P. Development of a single dose tetanus toxoid formulation based ion polymeric microspheres: a comparative study of poly(D,L-lactic-co- glycolic acid) versus chitosan microspheres. International. J. Pharm., 2005, 294, 23-32. (Pubitemid 40462320)
18. United States Pharmacopoeia, vol.29, n. 4.
19. Costa, M.H.B.; Sant'Anna, O.A.; de Araújo, P.S.; Sato, R.A.; Quintilio, W.; Silva, L.V.; Matos, C.R.; Raw, I. Conformational stability and antibody response to the 18kDa heat-shock protein formulated into different vehicles. Appl. Biochem Biotechnol., 1998, 73(1), 19-28. (Pubitemid 28380725)
20. Johansen, P.; Men, Y.; Merkle, H.P.; Gander, B. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. Eur. J. Pharm. and Biopharm., 2000, 50, 129-146 (Pubitemid 30326693)
21. Kersten, G.F.; Donders, D.; Akkermans, A.; Beuvery, E.C. Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen. Vaccine, 1996, 14(17-18), 1627-1632 (Pubitemid 27041914)
22. Sant'Anna, O.A.; Lima, F.A.; De Franco, M.; Ribeiro, O.G. Imunogenética e Resistência a Infecções. In: Mir, L, Rzezinski, P. (Ed.). Genômica, 2004 1st Ed., São Paulo.
23. Cox, J.C.; Coulter, A.R. Adjuvants - a classification and review of their modes of action. Vaccine, 1997, 15, 248-256 (Pubitemid 27116125)
24. Peyre, M.; Sesardic, D.; Merkle, H.P.; Gander, B.; Johansen, P. An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. J. Pharm. Sci., 2003, 92(5), 957-966. (Pubitemid 36523441)
25. Howard, C.R.; Beale, A.L.; Aguado, M.T. The development of controlled release vaccines - The role of the World Health Organisation. In: Gander, B.; Merkle, H.P.; Corradin G. (Ed.), Antigen delivery systems. Amsterdam: Harwood Academic Publishers, 1997, 1-14.
26. Singh, M.; Li, X.M.; Wang, H., McGee, J.P.; Zamb, T.; Koff, W.; Wang, C.Y.; O'Hagan D.T. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine. Infect. Immun., 1997, 65(5), 1716-1721 (Pubitemid 27193591)
27. Dutton, R.W.; Swain, S.L.; Bradley, L.M. The generation and maintenance of memory T and B cells. Immunol. Today, 1999, 20, 291-293